Type
Blood Testing
Biomarkers
11
Duration
30 min
Results
7 days
Sample
Cancer screening
What's included
3 deliverables in this treatment
- Tumor marker blood tests
- Risk assessment questionnaire
- Results interpretation and follow-up recommendations
Comprehensive tumor marker panel for early cancer detection including AFP, CEA, CA19-9, and PSA (male) or CA-125 (female).
About this treatment
Cancer risk screening uses blood-based tumor markers, genetic risk panels, or non-invasive tests to assess your risk for various cancers. Blood-based markers like PSA, CA-125, CEA, and AFP can detect elevated levels associated with certain cancer types. These tests are not diagnostic on their own but identify individuals who may benefit from further investigation.
Early detection dramatically improves outcomes for most cancers. Screening programs are especially valuable for those with family history, known genetic risk factors, or age-related risk increases.
Good to know
- Sample
- Blood draw (or stool for FIT)
- Fasting
- Usually not required
- Results
- 3–7 business days
Who is this for?
People with family history of cancer wanting proactive screening. Those over 40 wanting regular cancer risk monitoring. Anyone seeking peace of mind through early detection. People with known genetic risk factors (e.g., BRCA carriers).
Preparation required
No special fasting required for most tumor marker blood tests. For FIT (stool-based) screening, follow the kit instructions carefully. Bring relevant family history information.
Panel categories
Biomarkers tested
11A biomarker associated with some breast cancers; used to monitor treatment response in patients with metastatic breast cancer.
A biomarker commonly used in the diagnosis and management of pancreatic and gastrointestinal cancers. Elevated levels can also be found in other conditions such as liver disease.
Tumor marker; elevated levels may indicate certain cancers, particularly gastrointestinal cancers.
The cortisol awakening response (CAR) is a period of increased cortisol secretory activity initiated by morning awakening and typically peaking between 30 and 45min post awakening
Measures only the unbound PSA in the blood.
Imbalances in gut pH influence short-chain fatty acid production and their effects.
About the clinic
Reviews, team and credentials
Independent review links and clinic-reported team information.
Clinical team
Languages: thai, english
Treatment highlights
- Tumor marker blood tests
- Risk assessment questionnaire
+1 more item in What's included
